⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 23, 2024Open Access

Figure S1 from Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma

Catherine A. Behrmann Kelli N. Ennis P.N. Sarma Collin Wetzel Nicholas A. Clark Kate M. Von Handorf Subrahmanya Vallabhapurapu Cristina Andreani James Reigle Pier Paolo Scaglioni Jarek Meller Maria Czyzyk-Krzeska Ady Kendler Xiaoyang Qi Jann N. Sarkaria Mario Medvedovic Soma Sengupta Biplab Dasgupta David R. Plas

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Tumor growth and body weight

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Behrmann et al. (2024) studied this question.

synapsesocial.com/papers/68e5b3b6b6db64358754c8c0 https://doi.org/10.1158/2767-9764.26819626

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure 3 from Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma2024
2Figure 5 from Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma2024
3Data from Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma2024
4Figure 4 from Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma2024
5Figure 1 from Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma2024

More related papers

Coordinated targeting of S6K1/2 and AXL disrupts pyrimidine biosynthesis in PTEN-deficient glioblastoma2024
Figure 2 from Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma2024
Supplementary Figure S4 from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple <i>KRAS</i> Mutations and Inhibits Tumor Growth2024